– Reuters
Why Matinas BioPharma Stock Is Sinking Today
BioNTech SE (NASDAQ: BNTX) and Matinas BioPharma Holdings Inc (NYSE: MTNB) have ended an mRNA-based collaboration.
ConocoPhillips Says It Has Seen Some Inflationary Pressures In Its Alaska Willow Project; Says Its Current Cost Estimate For Willow Project Is Between $7B-$7.5B
– Reuters
Related Posts
META’s AI Tryst: Your Ad Dollars are About to Work Harder and Smarter, Analysts Highlight
Oppenheimer analyst Jason Helfstein maintains Meta Platforms Inc (NASDAQ:META) with an Outperform, raising the price target from $285 to $350. The analyst…
Why HubSpot Shares Are Trading Higher Today
HubSpot, Inc. (NYSE: HUBS) shares are trading about 6.5% higher at $280.83 per share Thursday afternoon after the company reported better-than-expected third-quarter financial results. The company also issued fourth-quarter and full-year 2022 guidance above estimates.
SpartanNash, Shipt Announce Expansion Of Same-Day Delivery Partnership
Food solutions company SpartanNash (the "Company") (NASDAQ:SPTN) today announced its growing partnership with same-day delivery service Shipt. Shipt users will now be able to shop nearly 90